This review aims to compile local epidemiological data on atrial fibrillation and oral anticoagulant use to better reflect the characteristics of the authors' society.
Highlights gaps in local AF epidemiology; leaves open translation to guidelines without prospective validation.
Atrial Fibrillation (AF) is the most common arrhythmia observed in clinical practice. While the thromboembolic events are the most feared complications, these complications alone are responsible for 15% of all strokes. Anticoagulation therapy is the most effective way to prevent this significant complication caused by AF. Due to the disadvantages related to the recently launched new oral anticoagulants, warfarin still maintains its dominance as the gold standard agent. Pharmaceutical agents as well as demographic characteristics (age, sex, the type of AF, co-morbidities etc.) of the patients are crucial to provide effective coagulation. Since most of the studies on demographic characteristics of AF patients and the profile of oral anticoagulant use originate from the West and Far East, they do not reflect the real characteristics of our country. In this study, by analyzing the epidemiological studies conducted among AF patients in our country, we aimed to bring literature in data related to our society.
No takes yet. Share an insight, caveat, or question.
Faruk Ertaş (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: